body: The Food and Drug Administration is fulfilling its negotiated Generic Drug User Fee Amendments commitments, Kathleen Uhl, director of the agency's Office of Generic Drugs, said on AAPS Pharmceutica, 1 week ago
FDA making progress with ANDA backlog - GaBi Online, 2 weeks ago
USFDA approvals won't help pharma cos get higher margins - Economic Times, 2 weeks ago
Summary Q1 2016 presents strong earnings growth due to modest increase in revenues and sharp rise in margins. Upcoming generic product launches increase optimism for 2016, and provide for continued top-line growth. Our price target moves to ...Seeking Alpha, 1 day ago
Third Quarter 2015 Highlights Full Year 2015 Financial Guidance IGI's President and Chief Executive Officer, Jason Grenfell-Gardner On the regulatory front, we have submitted ten ANDA submissions so far this year, including today's ...Wall Street Select, 1 month ago Stephen Richardson Appointed As Chief Scientific Officer Of IGI Laboratories, Inc. Marketplace, 1 month ago IGI Laboratories, Inc. Announces Ninth ANDA Submission Of 2015 Fat Pitch Financials, 1 month ago
CPhI Worldwide, organised by UBM EMEA, has announced the findings of the fourth and final section of its 2015 annual report, The Outsourcing perspective, live from CPhI Worldwide 2015 in Madrid. Four leading experts on the global pharma outsourcing ...European Pharmaceutical Review, 1 month ago
Shares of pharmaceutical companies are poised to outperform benchmark indices for the fifth consecutive calendar year, driven by a pick-up in USFDA approvals and a weak rupee, providing a double-boost to profitability and stock performance of ...Financial Express, 1 month ago
on your WebpageAdd Widget >Get your members hooked!